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Results: Indications for PVR were valvular regurgitation (n=6), obstruction (n=3), and
both (n=1). Valve types were St. Jude (n=7), Starr-Edwards (n=2), and Bjork-Shiley
(n=1). In 5 pts, the mechanical PVR was placed within a conduit. Concomitant mechani-
cal tricuspid valve replacement (St. Jude) was performed in 6 pts. Postoperatively, all but
1 were anticoagulated with warfarin. During late follow-up (8.3 +/- 7.7 yrs, max 25 yrs), 1
pt required repeat PVR for outgrowth of prosthesis 25 yrs postoperatively, and 1 pt with
normal prosthetic pulmonary valve function underwent heart transplantation for severe
biventricular failure 3.5 yrs postoperatively. The average mean gradient across the
mechanical PVR by echocardiography in the remaining 8 pts was 11 +/- 7 mmHg. There
were no perivalvular leaks or vegetations, and no evidence of pannus formation or pros-
thesis dysfunction. There were 3 late minor bleeding events (epistaxis in 2 pts and men-
orrhagia in 1). There was 1 sudden late death 15 yrs after PVR, and 1 death from
unknown causes in the aforementioned pt with outgrowth of the mechanical PVR, 5.5 yrs
post re-PVR with a bioprosthesis. There were no cases of pulmonary emboli or PVR
thrombosis.
Conclusions: Mechanical PVR appears to provide excellent durability and hemodynamic
results without mechanical valve failure or valve thrombosis in this small series. Mechan-
ical prostheses should be considered for PVR in selected pts, particularly those who
require chronic warfarin anticoagulation for other reasons.
11:45 a.m.
840-6 Coarctation Long-Term Assessment (COALA-Study) 
Incidence of Restenosis and Hypertension After 
Surgical Repair
Alfred Hager, Simone Kanz, Harald Kaemmerer, Christian Schreiber, John Hess, 
Deutsches Herzzentrim München, TUM, München, Germany
Background: to assess the incidence of restenosis and arterial hypertension in patients
after surgical repair of aortic coarctation in a cross sectional study.
Patients and Methods: From 1974 to now 405 patients born before 1.1.1965 underwent
surgery for isolated aortic coarctation in our hospital. From those 383 who are still alive
26 moved to remote or unknown areas and 83 denied a follow up examination at our
institution. The study group of the remaining 274 patients (16 - 73 years old, 90 female,
184 male, 72% of those that are still alive), 18.4 ± 5.9 years (range 1 - 27 years) after sur-
gery, underwent a structured clinical investigation with a Doppler sonographic measure-
ment of the blood pressure at all limbs, exercise test, and ambulatory blood pressure
measurement.
Results: 29 patients (11%) already underwent surgery for restenosis, another 20 patients
(7%) had a leg-arm gradient of more than 20 mmHg suggesting restenosis now. Risk fac-
tors were young age at the first repair and first repair without end-to-end anastomosis.
67 Patients (24%) were already on antihypertensive drug therapy, another 48 patients
(18%) had a mean systolic blood pressure of 134 mmHg or higher in ambulatory blood
pressure measurement and should therefore also be classified hypertensive. Further-
more, another 28 patients (10%) showed a blood pressure during exercise exceeding 2
SD of reference values. All in all, only 131 patients (48%) had a normal blood pressure
reaction. The only independent risk factors for an abnormal blood pressure was a repair
without end-to-end anastomosis. Other risk factors like age at repair, age at investigation,
and body weight at investigation were not significant in a multiple regression analysis
anymore.
Conclusions: In the long-term follow up 18% of patients after surgery for aortic coarcta-
tion show restenosis. An arterial hypertensive blood pressure reaction is much more
common in long term follow up with an incidence of 52%. In only few patients hyperten-
sion is due to restenosis. Best results were achieved in patients in whom an end-to-end
anastomosis could be performed and in whom repair was not performed at a very young
age.
POSTER SESSION
1152 Heart Failure, Exercise, and Risk Factors 
in Congenital Heart Disease
Tuesday, March 09, 2004, Noon-2:00 p.m.
Morial Convention Center, Hall G
Presentation Hour: 1:00 p.m.-2:00 p.m.
1152-199 Thromboembolic Events Among Children With 
Cardiomyopathy: Results From the National Australian 
Childhood Cardiomyopathy Study
Robert G. Weintraub, Patty Chondros, Alan Nugent, John Carlin, Piers E.F Daubeney, 
National Australian Childhood Cardiomyopathy Study, Melbourne, Australia
Background: Subjects with cardiomyopathy (CM) are at risk from thromboembolism.
There is little information about predisposing factors and the magnitude of the risk in chil-
dren.
Methods: The National Australian Childhood Cardiomyopathy Study is a population-
based study, including all children in Australia with primary CM who presented at 0-10
years of age. Cases were classified according to WHO criteria. A thromboembolic event
was defined as the finding of intracardiac thrombus, or onset of organ dysfunction related
to an embolic event. Risk factors examined included CM type, congestive heart failure
(CHF) at diagnosis, duration of inotropic therapy, mechanical ventilation, ICU and hospi-
tal stay at presentation. Children not surviving 24 hours from presentation were excluded
from survival analysis. Study end-points were death or transplantation.
Results: There were 314 patients diagnosed with CM during the study period, of which
299 were included in survival analysis. Of these, 19 (6.4%) of these developed throm-
boembolic complications, including 14/172 (8.1%) with dilated CM, 3/39 (7.7%) with
unclassified CM, 1/12 (8.5%) with restrictive CM and 1/80 (1.2%) with hypertrophic CM
(p=0.02 compared to other cases). 6 of 19 (31.6%) of thromboembolic events occurred
<2 days of presentation and 14 (73.7%) occurred <30 days. CHF at presentation was
related to risk of thromboembolism (hazard ratio 5.0; 95% CI: 1.6-21.8). The one and 5-
year survival free from thromboembolic events were 93% (95% CI: 89-96%) and 91%
(95% CI 84-95%), respectively, for children with dilated CM, and 92% (95% CI: 76-97%)
at both time points for children with unclassified CM. Embolic phenomena included a
cerebrovascular event in 5 cases and a pulmonary embolus in 1. The risk of death or
transplantation was significantly increased for all study patients with thromboembolism
(hazard ratio 4.2; 95%CI: 1.6-11.2) as well as for those with dilated CM alone (hazard
ratio 4.6; 95% CI: 1.45-14.6).
Conclusions: Thromboembolism occurs in up to 9% of children with CM within one year
of diagnosis and is related to early CHF and CM type. Thromboembolic complications
occur early and are associated with an increased risk of death or transplantation.
1152-200 N-Terminal Pro-B-Type Natriuretic Peptide Differentiates 
Lung From Heart Disease in Infants With Respiratory 
Distress
Shlomo Cohen, Chaim Springer, Zeev Perles, Azaria JJT Rein, Avraham Avital, Zvi 
Argaman, Amiram Nir, Hadassah University Hospital, Jerusalem, Israel, Shaarei Zedek 
Medical Center, Jerusalem, Israel
Background: Respiratory distress (RD) is a common symptom in infants. RD is usually
caused by lung disease, but can also be a result heart disease. It is often difficult do
determine the cause of RD. N-terminal pro-B-type natriuretic peptide (N-BNP) is co-
secreted along with BNP from cardiac myocytes. Like BNP, N-BNP is a marker for car-
diac volume and pressure overload.
Aim: To determine whether N-BNP levels can differentiate between lung disease and
heart disease in infant with RD.
Methods: Infants (age 1-36m) who presented at Hadassah University Hospital with RD
underwent physical examination, chest X-ray, arterial blood gases and echocardiogram.
Control N-BNP values were obtained from age-matched babies with no acute illness and
no history or signs for heart or lung disease. Plasma N-BNP levels were measured by
Electrochemiluminescence immunoassay (Roche, Germany).
Results: There were 18 infants with lung disease (laryngitis, pneumonia and RSV bron-
chiolitis), 19 infants with heart disease (myocarditis, dilated cardiomyopathy, atrio-ventric-
ular canal, hypertrophic cardiomyopathy and ventricular septal defect) and 16 healthy
infants. Infants with respiratory distress due to heart disease had significantly higher
plasma N-BNP than infants with respiratory distress due to lung disease or control
(table).
* p<0.001 vs lung and vs control; # p<0.05 vs control.
Conclusions: Plasma N-BNP can differentiate infants with RD due to heart disease form
infant with RD due to lung disease.
1152-201 Brain Natriuretic Peptide Correlates With Myocardial 
Performance Index in Congenital Heart Disease Patients
Alice A. Perlowski, John S. Child, Robert S. Ross, Pamela D. Miner, David Geffen School 
of Medicine-UCLA Medical Center, Los Angeles, CA
Background: The myocardial performance index (MPI) is an echocardiographic Dop-
pler-derived measure of ventricular function that has been previously validated in con-
genital heart disease(CHD) patients. It may be preferred over conventional non-invasive
measures of ventricular function in patients with complex anatomy, since it is neither
dependent on geometric shape nor heart rate. Although Brain Natriuretic Peptide (BNP)
is well described as a predictor of systolic and diastolic dysfunction in anatomically cor-
rect hearts, it is unclear how it relates to MPI in those with CHD.
Methods: We prospectively evaluated 54 adult patients with a broad range of both cyan-
otic and noncyanotic heart disease. Included were both surgically repaired and unre-
paired pts. Levels of BNP were measured in all subjects using standardized assays.
Doppler echocardiography was performed on the study subjects within six months of the
BNP assay. No subject had a change in functional clinical status during this interval.
Echo images were evaluated by an experienced observer blinded to BNP results and
clinical status. The MPI was calculated as the interval from AV valve closure to opening
minus ventricular ejection time, divided by ventricular ejection time. EF was calculated
with standard methodology by the same observer.
Results: Of a total of 54 patients with measurable left ventricular (LV) or univentricular
(UV) EFs, 34 had adequate data to calculate LV or UV MPIs. Of 30 pts with measurable
right ventricular (RV) EFs, 23 had adequate data to calculate RV MPIs. BNP was found to
be significantly correlated with LV/UV MPI (r= 0.461 with p= 0.006)and RV MPI (r= 0.748
with p < 0.0001) while LV/UV EF and RV EF had no significant correlation with BNP (r= -
0.189, p= 0.172; r= -0.066, p= 0.729, respectively) using a Pearson’s correlation coeffi-
cient test.
Conclusion: In patients with CHD, BNP correlates significantly with MPI but not with left,
right, or univentricular EF. This appears to be particularly true in the case of geometrically
Group Number Age-months
mean(±sd)
Respiratory rate
mean(±sd)
O2 saturation 
mean(±sd)
N-BNP (pg/ml) 
median
Control 16 14.3(5.4) 36(7.8) 97(1.4) 164
Lung 18 9.2(5.9) 62(16.1)# 89.4(3.7)# 311
Heart 19 11.9(12.3) 68(15.7)# 88.6(4.7)# 15403*
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variable right ventricles where EF may be more difficult to assess. These findings may
emphasize the unique ability of both BNP and MPI to assess global ventricular function in
geometrically complex hearts.
1152-202 Neurohormonal Activation in Children With Heart 
Failure Due to a Congenital Heart Defect
Dana Connolly, Sharda McGuire, Michael Artman, New York University School of 
Medicine, New York, NY
Background: Plasma norepinephrine (NE) and B-type natriuretic peptide (BNP) are use-
ful and accurate markers of heart failure severity in adults. Tumor necrosis factor-α (TNF-
α) has also been implicated in the neurohormonal response in adults with heart failure.
However, little is known about such responses in children. The purpose of this study was
to characterize neurohormonal activation due to heart failure in a representative sample
of children with congenital heart disease. Methods: Fifty-one children undergoing car-
diac surgery for a broad range of cardiac defects were studied. Previous cardiac surgery
had been performed in 45%. The study sample represented a wide age range (0 to 17
years; 5.3 ± 5.7; mean ± SD). On the day of surgery, heart failure severity was measured
using the New York University Pediatric Heart Failure Index (NYU PHFI) and systolic ven-
tricular function (left ventricular fractional shortening) was assessed using echocardio-
graphy. Fasting plasma NE, BNP and TNF-α levels were obtained under general
anesthesia before the surgical incision was made. Results: A strong correlation was
found between NE and BNP levels with heart failure severity (NYU PHFI scores) (Pear-
son correlations; NE: r = 0.41; p = 0.006; BNP: r = 0.63, p<0.001). Furthermore, ventricu-
lar function was inversely related to NYU PHFI (r = - 0.53; p< 0.001) and BNP levels = -
0.57; p = 0.002). In contrast, plasma TNF-α levels showed no correlation with either heart
failure severity, NE, BNP or ventricular function. Conclusions: Plasma TNF-α does not
reflect heart failure severity in children. In contrast, plasma NE and BNP levels are
directly related to the severity of heart failure, as indexed by NYU PHFI scores and the
degree of ventricular dysfunction. These results indicate that plasma BNP is a valid and
reliable measure of heart failure severity in infants, children and adolescents with con-
genital heart disease. Furthermore, the strong relationship between the degree of neuro-
hormonal activation (NE and BNP levels) and heart failure scores provides additional
validation of the NYU PHFI to quantify heart failure severity in the pediatric population.
1152-203 The Relationship of Age, Hemodynamics, and Severity 
of Illness With Brain Natriuretic Peptide Levels in 
Pediatric Heart Disease
Nancy Lin, Michael Landt, Kim Trinkaus, David Balzer, Henry Kort, Charles Canter, 
Washington University, St. Louis, MO
Background: Brain Natriuretic Peptide (BNP) blood levels correlate with hemodynamics
and severity of heart failure in adults. The validity of these relationships in pediatric heart
disease remain uncertain. Methods: We studied BNP levels in 216 pediatric patients
obtained prior to catheterization with a variety of cardiac lesions (2 ventricles/normal
anatomy-113, 2 ventricles left to right shunt-67, unrepaired right to left or bidirectional
shunt-28, post-operative Fontan-8). Severity of cardiac symptoms were graded on a 3
class scale with class 1= asymptomatic, 2= symptoms with activity, and 3= symptoms at
rest. 58 children were under 1 year of age, 45 between 1- 3 yr, 82 between 3-12 yr, and
31 > 13 yr. Results: Highly significant (p<0.0001), moderately strong correlations were
found with BNP levels and pulmonary capillary wedge pressure (r=0.40), Qp/Qs (r=0.39),
and mean pulmonary ventricular end-diastolic pressure (r=0.35). BNP levels rose signifi-
cantly (p<0.001) with functional class (medians: class 1=18 pg/ml, class 2=25 pg/ml,
class 3=540 pg/ml) and increasing age (p=0.026). Sex and race did not significantly cor-
relate with increases in BNP levels. Cardiac morphology did not impact on BNP level
independent of functional severity. For a given functional class, young patients tended to
have higher BNP levels, but this effect was not statistically significant. Conclusions: BNP
levels in pediatric heart disease correlate with increasing filling pressures and degree of
left to right shunting regardless of cardiac morphology. Elevated BNP levels appear to be
a marker for severe symptomatology with the potential, especially in infants and young
children, to enhance the detection of cardiac failure in pediatric heart disease.
1152-204 Exercise Capacity in Pediatric Heart Transplant 
Candidates
Bibhuti B. Das, Amy Taylor, Robert Wolfe, Anji T. Yetman, The Children's Hospital, 
Denver, CO
Background: Peak oxygen consumption (VO2) is a valuable tool in assessing adults with
congestive heart failure (CHF) being considered for cardiac transplantation (HT). A VO2
< 14 ml/kg/min, or a percent predicted VO2 <50% of normal, have been identified as
independant predictors of 1 year mortality and are used to determine timing of HT. The
feasibility of exercise testing and the role of VO2 measurement in children awaiting HT
have not been assessed. Method & Results: Cardiopulmonary stress testing using
cycle ergometry and a sensormedics metabolic cart was performed in 15 pediatric
patients listed, or being considered for HT at a mean age of 15.5 + 2.8 years and weight
of 46.4 + 10.1 kg. All patients went on to HT within a period of 5.9 + 5.3 months. The eti-
ology of CHF was ventricular dysfunction in the setting of a prior Fontan procedure in 4
and dilated cardiomyopathy in 11. A maximal stress test, as evidenced by a peak RQ
value >1.1 was obtained in 12 (80%) patients. Three patients had hemodynamic alter-
ations including desaturation <60% in 1, >3mm ST segment depression in 1 and ventric-
ular arrhythmias in 1. All resolved with cessation of exercise and there were no untoward
events. Peak VO2 was reduced at 18.6 + 5.2 ml/kg/min (42.6 + 12.8% predicted. Twelve
(86%) patients had a VO2 higher than the adult value of 14 ml/kg/min used for listing for
HT. Cardiac catheterization data from this population included a mean cardiac index of
2.6 + 0.6 L/m2, systemic ventricular end diastolic pressure of 18.0 + 6.6 mmHg, and pul-
monary vascular resistance index of 8.8 + 7.1 units*m2. Conclusion: In summary, car-
diopulmonary stress testing can be performed safely in children listed, or being
considered for, cardiac transplantation. Maximal tests can be obtained in the majority of
patients. The documented safety of this procedure may lead to greater utilization of
stress testing in this cohort of patients. Use of the adult peak VO2 value of <14 ml/kg/min
as a criterion for listing for HT is not applicable to children. Significant functional impair-
ment is noted at a much higher VO2. The adult transplant listing criterion of <50% pre-
dicted VO2 may be applicable to the pediatric population but requires further study.
1152-205 Exercise Responses in Children With Pulmonary 
Hypertension
Anji T. Yetman, Amy Taylor, Dunbar Ivy, University of Colorado Health Sciences Center, 
Denver, CO
Background: Adults with pulmonary hypertension (pHTN) have impaired aerobic capac-
ity when compred to healthy controls. Previous reports have shown that exercise testing
is a reproducible measure of disease severity and that peak oxygen consumption (VO2)
is predictive of 1 year mortality in adults with pHTN. Little is known regarding exercise
capacity in children with pHTN. Methods: We compared cardiopulmonary exercise
responses in children with pHTN (n=40) to healthy controls (CON, n=66). Maximal symp-
tom limited exercise was performed using cycle ergometry and a Sensormedics meta-
bolic system. Results: The etiology of the pHTN was primary in 15, congenital heart
disease in 17, and thromboemobolic/vascular disease in 8. Pulmonary vascular resis-
tance index (PVRI) at cardiac catheterization in the pHTN patients was 14.7 + 12.9
units*m2. No untoward events occurred during exercise testing. There were no differ-
ences in age (13.4 + 7.5 vs 13.8 + 2.9 years; p=0.7), gender (58% vs 57% male; p=NS)
or body mass index (19.1 + 3.9 vs 20.1 + 4.0 m2; p=0.2) between patients and controls.
Peak VO2 (20.9 + 7.0 vs 35.5 + 7.4 ml/kg/min; p<0.001), % predicted VO2 (47.4 + 14.2 %
vs 79.9 + 15.9% ; p<0.001), peak systolic blood pressure (141.7 + 22.3 vs 165.3 + 24.6
mmHg; p<0.001) and oxygen saturation at peak exercise (85.4% + 14.5 vs 94.5 + 3.3 %;
p<0.001) were significantly lower in pHTN vs CON. ∆ VE/∆ VCO2, a measure of ventila-
tory inefficiency, was significantly greater in pHTN than CON (46.8 + 10.9 vs 34.0 + 6.5;
p<0.001). The peak oxygen pulse, an indirect measure of stroke volume, was lower in
pHTN vs CON (5.3 + 2.3 vs 11.7 + 10.9 ml/beat; p<0.001). VO2 and % predicted VO2 in
patients with pHTN correlated with PVRI (r=-.59, p=.003 /r=-.65, p<0.001 respectively),
WHO class (r=-.58; p=.003), and ∆ VE/∆ VCO2 (r=-5.4, p<0.001/r=-.55, p<0.001 respec-
tively). Conclusion: Children with pHTN can safely undergo cardiopulmonary stress
testing. Exercise testing is a valuable tool in monitoring disease severity in children with
pHTN and may prove useful in assessing response to therapies. The degree of impair-
ment in aerobic capacity correlates well with other invasive measures of pulmonary vas-
cular disease.
1152-206 Cardiac Histopathologic Changes in Young Military 
Recruits Experiencing Sudden Death Due to Anomalous 
Coronary Origin Compared With Obstructive Coronary 
Artery Disease
Robert E. Eckart, Richard A. Krasuski, Stephen S. Reich, Paul D. Garrett, Charles L. 
Campbell, Eric A. Shry, Mark E. Peele, Brooke Army Medical Center, Fort Sam Houston, 
TX
Background: Sudden cardiac death (SCD) is a devastating event, particularly in the
young and otherwise healthy individual. The presence of an anomalous coronary artery,
though rare, is well established as a cause of SCD. Despite a postulated ischemic mech-
anism, it remains unclear what role chronic ischemia, fibrosis and myocardial cell death
plays in the fatal event.
Methods: We reviewed the clinical and autopsy records of all SCD occurring in military
recruits throughout the Department of Defense from 1977-2002.
Results: Thirty cases attributed to coronary artery lesions [10 with atherosclerotic coro-
nary artery disease (CAD) and 20 with anomalous coronary origin (ACO)] had full ana-
tomic and histological specimens available for direct comparison. Nearly all patients
examined were male (18/20 with CAD and 10/10 with ACO). Patients with CAD were
older (26.1±6.2 vs. 20.2±4.0 years, p=0.004) and weighed more (26.7±3.6 vs. 23.6±2.5
kg/m2, p=0.02). Patients with ACO were more likely to have had prodromal symptoms
(10/20 vs. 0/10, p=0.006), though there was no difference in the time of death from the
onset of physical training (36.0±20.0 vs. 28.8±12.5 days, p=NS). All SCD due to ACO
involved a left main coronary artery take-off from the right coronary sinus with a course
between the aorta and RVOT. In all cases of SCD due to CAD, obstructive disease
(>70%) of the left anterior descending coronary artery was present. Four of the patients
had multi-vessel disease. Myocardial fibrosis was seen equally in those with both CAD
and ACO (30% vs. 20%, p=0.66), but the finding of necrosis was more likely in individuals
with CAD (50% vs 15%, p=0.08). The incidence of either myocardial fibrosis or necrosis
in those CAD and ACO was 70% and 35% respectively (p=0.12).
Conclusions: Despite absence of prodromal symptoms, there was a 70% incidence of
histologic changes consistent with prior myocardial injury in SCD due to CAD. Silent
ischemia, with acute plaque rupture likely represents the causative factor behind SCD in
the young patient with CAD. Since patients with ACO frequently present antemortem with
anginal symptoms, it is imperative to identify the origin of the coronary arteries as poten-
tially causative.
